Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

USTEKINUMAB-STBA vs VALACYCLOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

USTEKINUMAB-STBA vs VALACYCLOVIR: Safety Overview

Metric USTEKINUMAB-STBA VALACYCLOVIR
Total FAERS Reports 184 13,138
Deaths Reported 16 812
Death Rate 8.7% 6.2%
Hospitalizations 33 6,169
Average Patient Age 49.7 yrs 60.9 yrs
% Female Patients 22.2% 56.3%
FDA Approval Date N/A Apr 3, 2012
Manufacturer N/A ST. MARY'S MEDICAL PARK PHARMACY
Route N/A ORAL
Marketing Status Prescription Prescription